Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis
- PMID: 15660254
- DOI: 10.1007/s10096-004-1266-6
Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis
Abstract
The aim of the present study was to compare the epidemiological and clinical characteristics of Streptococcus bovis endocarditis with those of endocarditis caused by oral streptococci, using data obtained from a large international database of uniformly defined cases of infective endocarditis. S. bovis, a well-known cause of infective endocarditis, remains the common name used to designate group D nonenterococcal streptococci. In some countries, the frequency of S. bovis endocarditis has increased significantly in recent years. Data from the International Collaboration on Endocarditis merged database was used to identify the main characteristics of S. bovis endocarditis and compared them with those of infective endocarditis (IE) due to oral streptococci. The database contained 136 cases of S. bovis IE and 511 cases of IE due to oral streptococci. Patients with S. bovis IE were significantly older those with IE due to oral streptococci (63+/-16 vs. 55+/-18 years, P<0.00001). The proportion of streptococcal IE due to S. bovis increased from 10.9% before 1989 to 23.3% after 1989 (P=0.0007) and was 56.7% in France as compared with 9.4% in the rest of Europe and 6.0% in the USA (P<0.00001). Patients with S. bovis IE had more comorbidity and never used intravenous drugs. Complication rates, rates of valve replacement, and mortality rates were similar in the two groups. In conclusion, this study confirmed that S. bovis IE has unique characteristics when compared to endocarditis due to oral streptococci and that it emerged in the 1990s, mainly in France, a finding that is yet unexplained.
Similar articles
-
Streptococcus bovis endocarditis: Update from a multicenter registry.Am Heart J. 2016 Jan;171(1):7-13. doi: 10.1016/j.ahj.2015.10.012. Epub 2015 Oct 21. Am Heart J. 2016. PMID: 26699595
-
Characteristics and regional variations of group D streptococcal endocarditis in France.Clin Microbiol Infect. 2007 Aug;13(8):770-6. doi: 10.1111/j.1469-0691.2007.01753.x. Epub 2007 May 14. Clin Microbiol Infect. 2007. PMID: 17501973
-
Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis.Eur J Clin Microbiol Infect Dis. 2008 Apr;27(4):285-91. doi: 10.1007/s10096-007-0441-y. Epub 2008 Jan 9. Eur J Clin Microbiol Infect Dis. 2008. PMID: 18183440
-
Infective endocarditis due to Streptococcus bovis in a series of nonaddict patients: clinical and morphological characteristics of 20 cases and review of the literature.Can J Cardiol. 2003 Sep;19(10):1139-45. Can J Cardiol. 2003. PMID: 14532939 Review.
-
Renal involvements in reported cases of Streptococcus bovis endocarditis.Int J Cardiol. 2015 Feb 15;181:179. doi: 10.1016/j.ijcard.2014.11.224. Epub 2014 Dec 13. Int J Cardiol. 2015. PMID: 25528307 Review. No abstract available.
Cited by
-
Intrauterine infection and postpartum bacteremia due to Streptococcus gallolyticus subsp gallolyticus: An emerging concern.IDCases. 2022 Jul 2;29:e01562. doi: 10.1016/j.idcr.2022.e01562. eCollection 2022. IDCases. 2022. PMID: 35815109 Free PMC article.
-
Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis.Front Cardiovasc Med. 2022 Mar 22;9:774189. doi: 10.3389/fcvm.2022.774189. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35391848 Free PMC article.
-
Characterization of a Four-Component Regulatory System Controlling Bacteriocin Production in Streptococcus gallolyticus.mBio. 2021 Jan 5;12(1):e03187-20. doi: 10.1128/mBio.03187-20. mBio. 2021. PMID: 33402539 Free PMC article.
-
Streptococcus gallolyticus Bacteremia: An Experience from a Tertiary Center in South India.Indian J Crit Care Med. 2020 Oct;24(10):943-945. doi: 10.5005/jp-journals-10071-23569. Indian J Crit Care Med. 2020. PMID: 33281319 Free PMC article.
-
Streptococcus gallolyticus abrogates anti-carcinogenic properties of tannic acid on low-passage colorectal carcinomas.Sci Rep. 2020 Mar 13;10(1):4714. doi: 10.1038/s41598-020-61458-5. Sci Rep. 2020. PMID: 32170212 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical